Territorial Availability: Available through Bertin Technologies only in France
- Correlated keywords
- Product Overview:
Cytokeratin 4 is a type II epithelial intermediate filament protein.{15723} It is composed of a central rod containing four ?-helical domains, which are important for self-assembly, and non-helical head and tail domains at the N- and C-termini, respectively. Cytokeratin 4 is expressed in mucosal stratified squamous epithelial cells, columnar luminal cells of the respiratory epithelium, and in non-stratified simple epithelial cells, with the highest expression in the esophagus and cornea.{52912} Cytokeratin 4 dimerizes with the type I epithelial intermediate filament protein cytokeratin 13, with the dimers then combining to form tetramers.{15723,52912} Mice lacking Krt4, the gene encoding cytokeratin 4, have disruptions in the epithelial integrity of the esophagus, tongue, and cornea, including basal hyperplasia, lack of cell maturation, and hyperkeratosis.{52913} Mutations in KRT4 have been associated with white sponge nevus, a disorder characterized by thickened white, spongy plaques on the oral mucosa.{52912} Cayman’s Cytokeratin 4 (C-Term) Rabbit Monoclonal Antibody can be used for immunohistochemistry (IHC) and Western blot applications.
Cayman Chemical’s mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.
Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.
Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.
Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.
Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009
Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.